The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease

By Cremieux Pierre-Yves   Van Audenrode Marc   Lefebvre Patrick  

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2329-2336

Informa Healthcare

Access to resources Recommend Favorite

Comments on Clinical and economic comparison of epoetin alfa and darbepoetin alfa

By Vanscoy Gordon J.   Sullivan Sean D.   Morreale Anthony P.  

Current Medical Research and Opinion, Vol. 20, Iss. 9, 2004-09 ,pp. : 1459-1463

Informa Healthcare

Access to resources Recommend Favorite

Dosing patterns, drug costs, and hematologic outcome in anemic patients with chronic kidney disease switching from darbepoetin alfa to epoetin alfa

By Hymes Jeffrey   Bickimer Tammy   Jackson James H.   Bookhart Brahim K.   Mody Samir H.   Tak Piech Catherine  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1931-1937

Informa Healthcare

Access to resources Recommend Favorite

Preference for monthly darbepoetin alfa dosing in patients with chronic kidney disease not receiving dialysis

By Hoggard Jeffrey   Crouch Thomas   McMurray Stephen   Levine Michael   Prathikanti Radha   Scarlata Debra   Audhya Paul  

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 2023-2030

Informa Healthcare

Access to resources Recommend Favorite

A randomised, cross-over study comparing injection site pain with subcutaneous epoetin beta and subcutaneous darbepoetin alfa in patients with chronic kidney disease

By Roger Simon D.   Suranyi Michael G.   Walker Rowan G.    

Current Medical Research and Opinion, Vol. 24, Iss. 8, 2008-08 ,pp. : 2181-2187

Informa Healthcare

Access to resources Recommend Favorite